Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-026147
Filing Date
2024-11-05
Accepted
2024-11-05 16:30:18
Documents
1
Period of Report
2024-11-04

Document Format Files

Seq Description Document Type Size
1 form4-11052024_041101.html 4  
1 form4-11052024_041101.xml 4 23298
  Complete submission text file 0001415889-24-026147.txt   24770
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1040 SPRING STREET SILVER SPRING MD 20910
Business Address
EDGEMOND JAMES (Reporting) CIK: 0001636178 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 241427941